Keyphrases
AMP-activated Kinase
11%
Antitumor Activity
100%
Antitumor Effect
33%
Array Data
22%
Cell Apoptosis
11%
Cell Cycle Progression
11%
Cell Death
11%
Cell Proliferation
11%
Cell Viability Assay
11%
Computational Analysis
11%
Crystal Violet Assay
11%
DNA Damage Response
11%
Energy Sensing
11%
Flow Cytometry
11%
Gamitrinib
100%
Glioma
100%
Glioma Cell Lines
22%
Glioma Cells
11%
Glioma Model
11%
Heat Shock Protein 90 (Hsp90)
100%
Human Glioma Cell Line
11%
Improved Survival
11%
Mitochondrial Biogenesis
22%
Mitochondrial Respiration
11%
Mitochondrial Targeting
100%
Multiple Gliomas
11%
Neurospheres
22%
Oxidative Phosphorylation (OXPHOS)
11%
Patient-derived Organoids
11%
Patient-derived Xenograft
22%
Primary Glioma
11%
Reverse Phase Protein Array
22%
RNA Sequencing (RNA-seq)
22%
Seahorse Assay
11%
Stress Response
11%
Temozolomide
22%
Therapeutic Efficacy
22%
Therapeutic Role
11%
Tumor
11%
Tumor Bioenergetics
11%
Tumor Growth
11%
Xenograft
22%
Medicine and Dentistry
Antineoplastic Activity
100%
Cell Cycle Progression
20%
Cell Proliferation
20%
Cell Viability Assay
20%
Combination Therapy
40%
Crystal Violet
20%
DNA Damage
20%
Flow Cytometry
20%
Ganglioglioma
100%
Glioma Cell
20%
Glioma Cell Line
60%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
20%
Mitochondrial Biogenesis
40%
Mitochondrial Respiration
20%
Neoplasm
40%
Organoid
20%
Programmed Cell Death
20%
Protein Microarray
40%
RNA Sequence
40%
Temozolomide
40%
Tumor Progression
20%
Xenograft
80%
Neuroscience
AMP-activated Protein Kinase
33%
Cell Cycle Progression
33%
Cell Line
100%
Cell Proliferation
33%
Cell Viability
33%
Crystal Violet
33%
DNA Damage
33%
Flow Cytometry
33%
Mitochondrial Biogenesis
66%
Mitochondrial Respiration
33%
Neurosphere
66%
Protein Microarray
66%
RNA Sequence
66%
Temozolomide
66%
Pharmacology, Toxicology and Pharmaceutical Science
Antitumor Activity
100%
Cell Viability
33%
Combination Therapy
66%
Crystal Violet
33%
Flow Cytometry
33%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
33%
Mouse
33%
Neoplasm
66%
RNA-Sequencing
66%
Seahorse
33%
Temozolomide
66%
Tumor Growth
33%
Viability Assay
33%
Immunology and Microbiology
Antineoplastic Activity
100%
Bioenergy
25%
Cell Cycle Progression
25%
Cell Proliferation
25%
Cell Viability
25%
DNA Damage
25%
Glioma Cell
25%
Glioma Cell Line
75%
Mitochondrial Biogenesis
50%
Mitochondrial Respiration
25%
Mouse
25%
Organoid
25%
RNA Sequence
50%
Seahorse
25%
Xenograft
100%